Sernova Agrees on Terms to Gain Access to Proprietary Stem Cell Technology For the Treatment of Diabetes
15 juil. 2014 06h00 HE
|
Sernova Corp.
LONDON, ONTARIO--(Marketwired - July 15, 2014) - Sernova Corp. (TSX VENTURE:SVA) a clinical stage company developing medical technologies for the long-term treatment of chronic metabolic...
Sernova Team Participates at Key US Life Sciences Event: 2014 BIO International Convention, San Diego
24 juin 2014 06h00 HE
|
Sernova Corp
LONDON, ONTARIO--(Marketwired - June 24, 2014) - Sernova Corp. (TSX VENTURE:SVA), a clinical stage company developing disruptive medical technologies for the long-term treatment of...
Sernova's CEO Dr. Philip Toleikis Featured on BNN
20 juin 2014 06h00 HE
|
Sernova Corp
LONDON, ONTARIO--(Marketwired - June 20, 2014) - Sernova Corp. (TSX VENTURE:SVA), a clinical stage company developing disruptive medical technologies for the long-term treatment of...
Sernova Provides Corporate Update and Results of 2014 Annual General Meeting
03 juin 2014 06h00 HE
|
Sernova Corp
LONDON, ONTARIO--(Marketwired - June 3, 2014) - Sernova Corp. (TSX VENTURE:SVA), a clinical stage company developing medical technologies for the long-term treatment of chronic...
Sernova Receives Patent Allowance for Cell Pouch(TM) and Therapeutic Cell Transplantation Technologies
14 mai 2014 06h00 HE
|
Sernova Corp.
LONDON, ONTARIO--(Marketwired - May 14, 2014) - Sernova Corp. (TSX VENTURE:SVA), today announced that the Australian Patent Office has issued a Notice of Acceptance to Sernova for its...
Kevin Egan Joins Sernova as Chair Business Advisory Board
12 mai 2014 06h00 HE
|
Sernova Corp.
LONDON, ONTARIO--(Marketwired - May 12, 2014) - Sernova Corp. (TSX VENTURE:SVA) is pleased to announce that Mr. Kevin M. Egan, President, Borealis Biotechnology LLC, an international...
Sernova Announces Appointment of Nick Borrelly to Corporate Development Role
07 mai 2014 06h00 HE
|
Sernova Corp.
LONDON, ONTARIO--(Marketwired - May 7, 2014) - Sernova Corp. (TSX VENTURE:SVA) is pleased to announce that Mr. Nick Borrelly is joining Sernova in a consultant corporate development role....
New Diabetes Therapy to Replace Insulin Injections
24 avr. 2014 10h30 HE
|
SERNOVA CORP
LONDON, Ontario, April 24, 2014 (GLOBE NEWSWIRE) -- Last week, a New York Times article by Elisabeth Rosenthal accused the medical industry of, "borrowing business models from technology companies...
Sernova's Cell Pouch(TM) Diabetes Clinical Trial Demonstrates Interim Safety and Biocompatibility
22 avr. 2014 06h00 HE
|
Sernova Corp.
LONDON, ONTARIO--(Marketwired - April 22, 2014) - Sernova Corp. (TSX VENTURE:SVA), a clinical stage company developing medical technologies for the long-term treatment of chronic...
Sernova Announces Annual Meeting, Record Date and Adopts Advance Notice By-Law
26 févr. 2014 06h00 HE
|
Sernova Corp
LONDON, ONTARIO--(Marketwired - Feb. 26, 2014) - Sernova Corp. (TSX VENTURE:SVA), a clinical stage company developing medical technologies for the long-term treatment of chronic...